Tagged:

Continental Health Body Launches Pan-African Study On Mpox

The Africa Centre Disease Control (CDC), with global health partners, has announced the launch of a "pivotal" clinical trial that aims to advance research for Mpox treatment across the continent.

In a statement, the continental health body said the study will begin by evaluating the safety and efficacy of brincidofovir, an antiviral currently approved for smallpox in the U.S.

"Africa is not just responding to the mpox outbreak, we are leading the charge in finding solutions by spearheading research and development for mpox therapeutics," said Africa CDC Director General, Dr. Jean Kaseya. He said the Mpox study is a "groundbreaking step" towards developing an effective treatment that will save lives.

The disease was declared a Public Health Emergency of Continental Security in August 2024.

InFocus

OMS / Halldorsson

Vials of Mpox vaccine.

InFocus

Follow AllAfrica

AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.